Hemoptysis medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Hemoptysis is a symptom that indicates an underlying pulmonary or extrapulmonary cause. Pharmacologic medical therapy depends on an underlying cause. However, the mainstay of treatment for massive hemoptysis is supportive and surgical therapy.
Hemoptysis is a symptom that indicates an underlying [[Lung|pulmonary]] or extrapulmonary cause. Pharmacologic medical therapy depends on an underlying cause. However, the mainstay of treatment for massive hemoptysis is supportive and [[Surgery|surgical therapy]].


==Medical Therapy==
==Medical Therapy==
*Hemoptysis is a symptom that indicates an underlying pulmonary or extrapulmonary cause.  
*Hemoptysis is a symptom that indicates an underlying [[Lung|pulmonary]] or extrapulmonary cause.  
*Pharmacologic medical therapy depends on an underlying cause.
*Pharmacologic medical therapy depends on an underlying cause.
*The mainstay of treatment for massive hemoptysis is supportive and surgical therapy.
*The mainstay of treatment for massive hemoptysis is supportive and surgical therapy.
Line 17: Line 17:
** Preferred regimen (3): [[drug name]] 500 mg q12h for 14-21 days
** Preferred regimen (3): [[drug name]] 500 mg q12h for 14-21 days
** Alternative regimen (1): [[drug name]] 500 mg PO q6h for 7–10 days   
** Alternative regimen (1): [[drug name]] 500 mg PO q6h for 7–10 days   
** Alternative regimen (2): [[drug name]] 500 mg PO q12h for 14–21 days
** Alternative regimen (3): [[drug name]] 500 mg PO q6h for 14–21 days


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 19:13, 26 February 2018

Hemoptysis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemoptysis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemoptysis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemoptysis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemoptysis medical therapy

CDC on Hemoptysis medical therapy

Hemoptysis medical therapy in the news

Blogs on Hemoptysis medical therapy

Directions to Hospitals Treating Hemoptysis

Risk calculators and risk factors for Hemoptysis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]

Overview

Hemoptysis is a symptom that indicates an underlying pulmonary or extrapulmonary cause. Pharmacologic medical therapy depends on an underlying cause. However, the mainstay of treatment for massive hemoptysis is supportive and surgical therapy.

Medical Therapy

  • Hemoptysis is a symptom that indicates an underlying pulmonary or extrapulmonary cause.
  • Pharmacologic medical therapy depends on an underlying cause.
  • The mainstay of treatment for massive hemoptysis is supportive and surgical therapy.

Disease Name

  • 1 Stage 1 - Massive hemoptysis
    • Preferred regimen (1): drug name 100 mg PO q12h for 10-21 days (Contraindications/specific instructions)
    • Preferred regimen (2): drug name 500 mg PO q8h for 14-21 days
    • Preferred regimen (3): drug name 500 mg q12h for 14-21 days
    • Alternative regimen (1): drug name 500 mg PO q6h for 7–10 days

References